(Q55461469)

12 July 2018

title

The short chain cell-permeable ceramide (C6) restores cell apoptosis and perifosine sensitivity in cultured glioblastoma cells. (English)

1 reference

12 July 2018

1 reference

1 reference

Li-sen Qin

1

1 reference

12 July 2018

Zheng-quan Yu

2

1 reference

12 July 2018

Shi-ming Zhang

3

1 reference

12 July 2018

Guan Sun

4

1 reference

12 July 2018

Jian Zhu

5

1 reference

12 July 2018

Jin Xu

6

1 reference

12 July 2018

Jun Guo

7

1 reference

12 July 2018

Lin-shan Fu

8

1 reference

12 July 2018

publication date

25 September 2013

1 reference

12 July 2018

Molecular Biology Reports

published in

1 reference

12 July 2018

volume

40

1 reference

12 July 2018

issue

10

1 reference

12 July 2018

page(s)

5645-5655

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/s11033-013-2666-4

exact match

0 references

cites work

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Recent advances in therapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Trojan-horse nanotube on-command intracellular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

mTOR and cancer: insights into a complex relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Enhancing perifosine's anticancer efficacy by preventing autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

A protein conjugation system essential for autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

A ubiquitin-like system mediates protein lipidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Induction of autophagy and inhibition of tumorigenesis by beclin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Ceramide: a stress signal and mediator of growth suppression and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Ceramide: an intracellular signal for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Review: autophagy in neurodegeneration: firefighter and/or incendiarist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Self-eating and self-killing: crosstalk between autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Autophagy in cell death: an innocent convict?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Autophagy as a cell death and tumor suppressor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2666-4

Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest

21 January 2018

1 reference

12 December 2020

Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation

1 reference

12 December 2020

Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells

1 reference

12 December 2020

D-21266, a new heterocyclic alkylphospholipid with antitumour activity

1 reference

12 December 2020

10.1007/S11033-013-2666-4

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018